CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bausch Health Companies Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bausch Health Companies Inc
2150 Saint-Elzear Blvd W
Phone: (514) 744-6792p:514 744-6792 LAVAL, QC  H7L 4A8  Canada Ticker: BHCBHC
Business Summary
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-YesYesYes-

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202012/31/2019Yes--YesYes

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
3841 Surgical and medical instruments and apparatus
3842 Orthopedic, prosthetic, and surgical appliances and supplies
3843 Dental equipment and supplies
3851 Ophthalmic goods

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer Joseph C.Papa 64 5/2/2016 5/2/2016
Chief Financial Officer, Executive Vice President Paul S.Herendeen 64 8/22/2016 8/22/2016
President & Co-Head Bausch + Lomb/International Thomas J.Appio 58 8/1/2018 4/1/2016
8 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Valeant Pharmaceuticals Ireland Limited 3013 Citywest Business Campus Dublin Ireland
Jelfa S.A. 21 Wincentego Pola Str. Jelenia Gora Poland
Sanitas AB Veiveriu str. 134B KAUNAS Lithuania
23 additional Subsidiary records available in full report.

Business Names
Business Name
0909657 B.C. Ltd.
0919837 B.C. Ltd.
0938638 B.C. Ltd.
321 additional Business Names available in full report.

General Information
Number of Employees: 21,700 (As of 12/31/2019)
Outstanding Shares: 354,993,160 (As of 7/30/2020)
Shareholders: 1,853
Stock Exchange: TSE
Fax Number: (514) 744-6272


Copyright © 2020 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, August 9, 2020